Evidence map›Paper›PMID 32196864›Full record

ArticleChembiochem : a European journal of chemical biology2020

New Nocobactin Derivatives with Antimuscarinic Activity, Terpenibactins A-C, Revealed by Genome Mining of Nocardia terpenica IFM 0406.

Julia Chen, Andri Frediansyah, Daniel Männle, Jan Straetener, Heike Brötz-Oesterhelt, Nadine Ziemert, Leonard Kaysser, Harald Gross

Abstract read
In one paragraph

Article in Chembiochem : a European journal of chemical biology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Nobachelins, new siderophores fromSynthetic and systems biotechnology · 2023
    Article
  7. Article
  8. Bioinformatics-Guided Discovery of Biaryl-Tailored Lasso Peptides.bioRxiv : the preprint server for biology · 2023
    Article
  9. Article
  10. Amamistatins isolated fromBeilstein journal of organic chemistry · 2022
    Article
  11. Article
  12. Article
  13. ImprovedMicrobiology resource announcements · 2020
    Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Julia ChenPharmaceutical Institute, Dept. of Pharmaceutical Biology, University of Tübingen, Auf der Morgenstelle 8, 72076, Tübingen, Germany.
Andri FrediansyahPharmaceutical Institute, Dept. of Pharmaceutical Biology, University of Tübingen, Auf der Morgenstelle 8, 72076, Tübingen, Germany.
Daniel MännlePharmaceutical Institute, Dept. of Pharmaceutical Biology, University of Tübingen, Auf der Morgenstelle 8, 72076, Tübingen, Germany.
Jan StraetenerGerman Center for Infection Research (DZIF) Partner site Tübingen, 72076, Tübingen, Germany.
Heike Brötz-OesterheltGerman Center for Infection Research (DZIF) Partner site Tübingen, 72076, Tübingen, Germany.
Nadine ZiemertGerman Center for Infection Research (DZIF) Partner site Tübingen, 72076, Tübingen, Germany.
Leonard KaysserPharmaceutical Institute, Dept. of Pharmaceutical Biology, University of Tübingen, Auf der Morgenstelle 8, 72076, Tübingen, Germany.
Harald GrossPharmaceutical Institute, Dept. of Pharmaceutical Biology, University of Tübingen, Auf der Morgenstelle 8, 72076, Tübingen, Germany.ORCID 0000-0002-0731-821X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We report a genomics-guided exploration of the metabolic potential of the brasilicardin producer strain Nocardia terpenica IFM 0406. Bioinformatics analysis of the whole genome sequence revealed the presence of a biosynthetic gene cluster presumably responsible for the generation of formerly unknown nocobactin derivatives. Mass spectrometry-assisted isolation led to the identification of three new siderophores, terpenibactins A (1), B (2) and C (3), which belong to the class of nocobactins. Their structures were elucidated by employing spectroscopic techniques. Compounds 1-3 demonstrated inhibitory activity towards the muscarinic M3 receptor, while exhibiting only a low cytotoxicity.

Indexed as

Data MiningGenomicsComputer SimulationMultigene FamilyMuscarinic AntagonistsNocardiaOxazolesMuscarinic AntagonistsnocobactinsOxazoles

Identifiers

PMID32196864
PMCPMC7497119

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.